Based on a representative sample of the population, they found that the overall prevalence of probable neuropathic pain was 10 percent, with Hispanic and Black people more likely to experience it than white people
Amino Acids 43 (3), 13311337
PMID: 33922654 21 Unraveling Riboflavin-Mediated Mitochondrial Modulation as a Therapeutic Pathway in Neurological Disorders: An Integrative Systematic Review
Information provided is for educational purposes only.
If youre ready to take the next step toward optimizing your health, we invite you to learn more about our approach and see how we can help you
Thus, in perfect agreement with the recent ADA-EASD consensus report [6], we also encourage the adoption of GLP-1RA plus SGLT2i combination therapy in T2DM patients with established ASCVD (coronary artery disease, cerebrovascular disease, or peripheral arterial disease) or multiple risk factors for ASCVD (i.e., age 55 years, obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria) whose HbA1c remains suboptimal despite initial treatment with only one of these agents